Firestone Capital Management Zynerba Pharmaceuticals, Inc. Transaction History

Firestone Capital Management

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$2.88 - $4.3 $1,440 - $2,150	-500 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$3.33 - $8.76 $1,665 - $4,380	500 New	500 $2,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Firestone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Firestone Capital Management with notifications on news.